ASX - By Stock
|
SPL |
Re:
Ironwood abandons deal with AstraZeneca
|
|
UTexas80
|
8 |
4.0K |
0 |
08/08/18 |
08/08/18 |
ASX - By Stock
|
8
|
4.0K
|
0
|
|
ASX - By Stock
|
SPL |
Ironwood abandons deal with AstraZeneca
|
|
UTexas80
|
8 |
4.0K |
0 |
08/08/18 |
08/08/18 |
ASX - By Stock
|
8
|
4.0K
|
0
|
|
ASX - By Stock
|
SPL |
The Tampon Tax Repealed
|
|
UTexas80
|
0 |
1.2K |
3 |
02/08/18 |
02/08/18 |
ASX - By Stock
|
0
|
1.2K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Very high volume
|
|
UTexas80
|
26 |
11K |
9 |
02/08/18 |
02/08/18 |
ASX - By Stock
|
26
|
11K
|
9
|
|
ASX - By Stock
|
SPL |
Another Interview-Executive Series 10 Jul 18: Starpharma (SPL) CEO, Dr Jackie Fairley
|
|
UTexas80
|
24 |
10K |
15 |
12/07/18 |
12/07/18 |
ASX - By Stock
|
24
|
10K
|
15
|
|
ASX - By Stock
|
SPL |
Re:
We need a new thread - someone should start one
|
|
UTexas80
|
7 |
4.5K |
3 |
10/07/18 |
10/07/18 |
ASX - By Stock
|
7
|
4.5K
|
3
|
|
ASX - By Stock
|
SPL |
Found on LinkedIn
|
|
UTexas80
|
6 |
3.9K |
15 |
09/05/18 |
09/05/18 |
ASX - By Stock
|
6
|
3.9K
|
15
|
|
ASX - By Stock
|
SPL |
Australia the not-so-secret destination...
|
|
UTexas80
|
0 |
342 |
2 |
02/05/18 |
02/05/18 |
ASX - By Stock
|
0
|
342
|
2
|
|
ASX - By Stock
|
SPL |
Positive Money Flow
|
|
UTexas80
|
0 |
475 |
6 |
19/04/18 |
19/04/18 |
ASX - By Stock
|
0
|
475
|
6
|
|
ASX - By Stock
|
SPL |
Interesting advice from our fellow Australian Harry Newton
|
|
UTexas80
|
1 |
758 |
1 |
20/03/18 |
20/03/18 |
ASX - By Stock
|
1
|
758
|
1
|
|
ASX - By Stock
|
SPL |
Re:
A picture paints a thousand words
|
|
UTexas80
|
65 |
24K |
4 |
15/03/18 |
15/03/18 |
ASX - By Stock
|
65
|
24K
|
4
|
|
ASX - By Stock
|
SPL |
AstraZeneca spinout
|
|
UTexas80
|
0 |
552 |
4 |
28/02/18 |
28/02/18 |
ASX - By Stock
|
0
|
552
|
4
|
|
ASX - By Stock
|
SPL |
AZ has been busy...
|
|
UTexas80
|
2 |
1.3K |
6 |
23/02/18 |
23/02/18 |
ASX - By Stock
|
2
|
1.3K
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Viralytics gobbled up.....Why not Starpharma
|
|
UTexas80
|
26 |
11K |
4 |
22/02/18 |
22/02/18 |
ASX - By Stock
|
26
|
11K
|
4
|
|
ASX - By Stock
|
SPL |
Thought this might be a much needed distraction
|
|
UTexas80
|
3 |
1.4K |
2 |
06/02/18 |
06/02/18 |
ASX - By Stock
|
3
|
1.4K
|
2
|
|
ASX - By Stock
|
SPL |
SPL ->Top 30 Momentum Stock: $2.75 Target
|
|
UTexas80
|
2 |
1.6K |
8 |
26/01/18 |
26/01/18 |
ASX - By Stock
|
2
|
1.6K
|
8
|
|
ASX - By Stock
|
SPL |
Re:
Ann: Appendix 4C - Quarterly Cashflow Report
|
|
UTexas80
|
45 |
38K |
0 |
26/01/18 |
26/01/18 |
ASX - By Stock
|
45
|
38K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
Interesting Chart [in]action
|
|
UTexas80
|
3 |
1.5K |
6 |
23/01/18 |
23/01/18 |
ASX - By Stock
|
3
|
1.5K
|
6
|
|
ASX - By Stock
|
SPL |
Interesting Chart [in]action
|
|
UTexas80
|
3 |
1.5K |
2 |
23/01/18 |
23/01/18 |
ASX - By Stock
|
3
|
1.5K
|
2
|
|
ASX - By Stock
|
SPL |
Vaginitis Therapeutics Market to Flourish with an Impressive CAGR During 2017 - 2025
|
|
UTexas80
|
5 |
1.7K |
6 |
20/11/17 |
20/11/17 |
ASX - By Stock
|
5
|
1.7K
|
6
|
|
ASX - By Stock
|
SPL |
Starpharma Shout Out: global-conjunctivitis
|
|
UTexas80
|
0 |
427 |
6 |
25/10/17 |
25/10/17 |
ASX - By Stock
|
0
|
427
|
6
|
|
ASX - By Stock
|
SPL |
Re:
Simply Wall Street article -> Should you buy Starpharma
|
|
UTexas80
|
8 |
3.4K |
3 |
20/10/17 |
20/10/17 |
ASX - By Stock
|
8
|
3.4K
|
3
|
|
ASX - By Stock
|
SPL |
Simply Wall Street article -> Should you buy Starpharma
|
|
UTexas80
|
8 |
3.4K |
0 |
19/10/17 |
19/10/17 |
ASX - By Stock
|
8
|
3.4K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
StarpharmaTightly Held - Supply is Diminishing - Interesting Big Holders on Registry
|
|
UTexas80
|
44 |
12K |
4 |
05/10/17 |
05/10/17 |
ASX - By Stock
|
44
|
12K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: AstraZeneca presents 1st DEP candidate as Bcl2/xL inhibitor
|
|
UTexas80
|
80 |
23K |
3 |
03/10/17 |
03/10/17 |
ASX - By Stock
|
80
|
23K
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Ann: DEP docetaxel positive phase 1 results, phase 2 commences
|
|
UTexas80
|
130 |
42K |
1 |
24/09/17 |
24/09/17 |
ASX - By Stock
|
130
|
42K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Jackie continues to talk about Okamoto and VivaGel
|
|
UTexas80
|
15 |
6.8K |
0 |
04/09/17 |
04/09/17 |
ASX - By Stock
|
15
|
6.8K
|
0
|
|
ASX - By Stock
|
SPL |
Re:
What news
|
|
UTexas80
|
19 |
5.4K |
2 |
31/08/17 |
31/08/17 |
ASX - By Stock
|
19
|
5.4K
|
2
|
|
ASX - By Stock
|
SPL |
Gilead to Buy Kite Pharma for Roughly $11 Billion
|
|
UTexas80
|
0 |
357 |
3 |
29/08/17 |
29/08/17 |
ASX - By Stock
|
0
|
357
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma Shout out
|
|
UTexas80
|
2 |
799 |
2 |
29/08/17 |
29/08/17 |
ASX - By Stock
|
2
|
799
|
2
|
|
ASX - By Stock
|
SPL |
Starpharma Shout out
|
|
UTexas80
|
2 |
799 |
1 |
28/08/17 |
28/08/17 |
ASX - By Stock
|
2
|
799
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Using a P/E of 20
|
|
UTexas80
|
25 |
5.7K |
4 |
09/08/17 |
09/08/17 |
ASX - By Stock
|
25
|
5.7K
|
4
|
|
ASX - By Stock
|
SPL |
Today's Volume / Price Appreciation
|
|
UTexas80
|
2 |
701 |
7 |
07/08/17 |
07/08/17 |
ASX - By Stock
|
2
|
701
|
7
|
|
ASX - By Stock
|
SPL |
Wall Street is making huge bets on healthcare companies you've never heard of -
|
|
UTexas80
|
2 |
773 |
3 |
21/07/17 |
21/07/17 |
ASX - By Stock
|
2
|
773
|
3
|
|
ASX - By Stock
|
SPL |
Re:
Calm before the storm
|
|
UTexas80
|
18 |
5.7K |
1 |
13/07/17 |
13/07/17 |
ASX - By Stock
|
18
|
5.7K
|
1
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma is one of Bell Potter top picks for FY18
|
|
UTexas80
|
41 |
12K |
2 |
07/07/17 |
07/07/17 |
ASX - By Stock
|
41
|
12K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
Starpharma is one of Bell Potter top picks for FY18
|
|
UTexas80
|
41 |
12K |
3 |
07/07/17 |
07/07/17 |
ASX - By Stock
|
41
|
12K
|
3
|
|
ASX - By Stock
|
SPL |
Starpharma Technical Analysis
|
|
UTexas80
|
0 |
2.0K |
2 |
01/07/17 |
01/07/17 |
ASX - By Stock
|
0
|
2.0K
|
2
|
|
ASX - By Stock
|
SPL |
Re:
has the worm turned
|
|
UTexas80
|
129 |
33K |
0 |
19/06/17 |
19/06/17 |
ASX - By Stock
|
129
|
33K
|
0
|
|
ASX - By Stock
|
SPL |
spl looking to hire quality mgr/sr quality asc
|
|
UTexas80
|
0 |
480 |
0 |
03/01/13 |
03/01/13 |
ASX - By Stock
|
0
|
480
|
0
|
|
ASX - By Stock
|
SPL |
spl looking to hire an ag research program mgr
|
|
UTexas80
|
4 |
4.0K |
4 |
20/12/12 |
20/12/12 |
ASX - By Stock
|
4
|
4.0K
|
4
|
|
ASX - By Stock
|
SPL |
Re:
Ann: VivaGel phase 3 study results
|
|
UTexas80
|
23 |
2.8K |
2 |
29/11/12 |
29/11/12 |
ASX - By Stock
|
23
|
2.8K
|
2
|
|
ASX - By Stock
|
SPL |
starpharma rides innovation to success
|
|
UTexas80
|
2 |
530 |
10 |
30/05/12 |
30/05/12 |
ASX - By Stock
|
2
|
530
|
10
|
|
ASX - By Stock
|
SPL |
sellers keep their powder dry
|
|
UTexas80
|
0 |
261 |
0 |
28/04/12 |
28/04/12 |
ASX - By Stock
|
0
|
261
|
0
|
|
ASX - By Stock
|
SPL |
short mention of starpharma...
|
|
UTexas80
|
0 |
345 |
1 |
25/04/12 |
25/04/12 |
ASX - By Stock
|
0
|
345
|
1
|
|
ASX - By Stock
|
SPL |
is the healthcare sector in good shape?
|
|
UTexas80
|
0 |
264 |
4 |
12/04/12 |
12/04/12 |
ASX - By Stock
|
0
|
264
|
4
|
|
ASX - By Stock
|
SPL |
m&g acquires more shares...
|
|
UTexas80
|
1 |
380 |
3 |
31/03/12 |
31/03/12 |
ASX - By Stock
|
1
|
380
|
3
|
|
ASX - By Stock
|
SPL |
Re:
global nanobiotechnology market to reach...
|
|
UTexas80
|
3 |
443 |
0 |
30/03/12 |
30/03/12 |
ASX - By Stock
|
3
|
443
|
0
|
|
ASX - By Stock
|
SPL |
global nanobiotechnology market to reach...
|
|
UTexas80
|
3 |
443 |
11 |
29/03/12 |
29/03/12 |
ASX - By Stock
|
3
|
443
|
11
|
|
ASX - By Stock
|
SPL |
searching for australia's best biotech stocks
|
|
UTexas80
|
2 |
331 |
2 |
26/03/12 |
26/03/12 |
ASX - By Stock
|
2
|
331
|
2
|
|